Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05581173 · ClinicalTrials.gov registry record
Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 41
- Enrollment target
NCT05581173 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 41 participants.
The verdict
NCT05581173 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The study is designed as a multicenter prospective registry study evaluating the efficacy of the self-assembling peptide in the prevention of stricture formation after endoscopic resection as part of standard medical care. No experimental interventions will be performed.
Interventions
- DEVICE Purastat SAP gel application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2025-01-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05581173
The ClinicalTrials.gov registry entry for NCT05581173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Purastat SAP gel application is the first listed.
NCT05581173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05581173 about?
NCT05581173 is a clinical study titled "Self-Assembling Matrix Forming Gel to Prevent Stricture Formation". The study is designed as a multicenter prospective registry study evaluating the efficacy of the self-assembling peptide in the prevention of stricture formation after endoscopic resection as part of standard medical care. No experimental interventions will be performed.
What is the current status of trial NCT05581173?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2022-09-19. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT05581173?
The interventions under investigation include: Purastat SAP gel application (DEVICE).
Who is sponsoring clinical trial NCT05581173?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.